MDMB-BINACA

Identifiers
IUPAC name methyl (2S)-2-[(1-butylindazole-3-carbonyl)amino]-3,3-dimethylbutanoate
PubChemCID	165361538
ChemSpider	79413388
UNII	AN7ERQ8YHM
Chemical and physical data
Formula	C19H27N3O3
Molar mass	345.443 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCN1C2=CC=CC=C2C(=N1)C(=O)N[C@H](C(=O)OC)C(C)(C)C
InChI InChI=1S/C19H27N3O3/c1-6-7-12-22-14-11-9-8-10-13(14)15(21-22)17(23)20-16(18(24)25-5)19(2,3)4/h8-11,16H,6-7,12H2,1-5H3,(H,20,23)/t16-/m1/s1 Key:YHAWFWPNIXPRDT-MRXNPFEDSA-N

MDMB-BINACA (MDMB-BUTINACA) is anindazole-3-carboxamide basedsynthetic cannabinoid receptor agonist that has been sold as adesigner drug, first identified in Sweden in May 2023. It has a similar chemical structure to potent cannabinoid agonists previously reported such asADB-BUTINACA andMDMB-5'Br-BUTINACA, and is believed to have similar effects.^[1]

• 4F-MDMB-BINACA
• ADB-5'F-BUTINACA
• ADB-5'Br-BUTINACA
• JWH-073

Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Cannabinoids
• Designer drugs
• Amides
• Tert-butyl compounds
• Indazolecarboxamides
• Methyl esters
• Cannabinoid stubs

• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Chemical articles without CAS registry number
• Articles without EBI source
• Chemical pages without DrugBank identifier
• Articles without KEGG source
• Drugs missing an ATC code
• Drugs with no legal status
• Articles containing unverified chemical infoboxes
• All stub articles